236 related articles for article (PubMed ID: 35379511)
1. Clinicopathological factors influencing the number of stages of Mohs surgery for basal cell carcinoma.
Calvão J; Pinho A; Brinca A; Vieira R
An Bras Dermatol; 2022; 97(3):291-297. PubMed ID: 35379511
[TBL] [Abstract][Full Text] [Related]
2. Surgical margins required for basal cell carcinomas treated with Mohs micrographic surgery according to tumor features.
Cerci FB; Kubo EM; Werner B; Tolkachjov SN
J Am Acad Dermatol; 2020 Aug; 83(2):493-500. PubMed ID: 32289390
[TBL] [Abstract][Full Text] [Related]
3. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
4. Correlation of basal cell carcinoma subtype with histologically confirmed subclinical extension during Mohs micrographic surgery: A prospective multicenter study.
Lim GF; Perez OA; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2022 Jun; 86(6):1309-1317. PubMed ID: 35231546
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study.
Sin CW; Barua A; Cook A
Int J Dermatol; 2016 Sep; 55(9):1044-7. PubMed ID: 27152747
[TBL] [Abstract][Full Text] [Related]
6. Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study.
Fantini BC; Bueno Filho R; Chahud F; Souza CDS
J Dermatolog Treat; 2019 Feb; 30(1):74-80. PubMed ID: 29727201
[TBL] [Abstract][Full Text] [Related]
7. Non-Melanoma Skin Cancer Tumor's Characteristics and Histologic Subtype as a Predictor for Subclinical Spread and Number of Mohs Stages required to Achieve Tumor-Free Margins.
Santos-Arroyo A; Carrasquillo OY; Cardona R; Sánchez JL; Valentín-Nogueras S
P R Health Sci J; 2019 Mar; 38(1):40-45. PubMed ID: 30924914
[TBL] [Abstract][Full Text] [Related]
8. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study.
Weesie F; Naus NC; Vasilic D; Hollestein LM; van den Bos RR; Wakkee M
Br J Dermatol; 2019 May; 180(5):1176-1182. PubMed ID: 30536656
[TBL] [Abstract][Full Text] [Related]
10. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.
Mosterd K; Krekels GA; Nieman FH; Ostertag JU; Essers BA; Dirksen CD; Steijlen PM; Vermeulen A; Neumann H; Kelleners-Smeets NW
Lancet Oncol; 2008 Dec; 9(12):1149-56. PubMed ID: 19010733
[TBL] [Abstract][Full Text] [Related]
11. Adamantinoid basal cell carcinoma: a predictor of more-aggressive clinical behavior.
Berk DR; Ball Arefiev KL; Gladstone HB
Dermatol Surg; 2012 Aug; 38(8):1346-50. PubMed ID: 22551358
[TBL] [Abstract][Full Text] [Related]
12. Mohs micrographic surgery for periocular skin cancer: a single-institution experience.
Shi K; Wang L; Srivastava D; Nijhawan RI
Arch Dermatol Res; 2023 Jul; 315(5):1181-1186. PubMed ID: 36464757
[TBL] [Abstract][Full Text] [Related]
13. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
14. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA;
Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for complicated Mohs surgery in the South Sweden Mohs Cohort.
Nätterdahl C; Kappelin J; Persson B; Lundqvist K; Ahnlide I; Saleh K; Ingvar Å
J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):1113-1117. PubMed ID: 35366359
[TBL] [Abstract][Full Text] [Related]
16. Periocular basal cell carcinoma recurrence following surgical treatment: Safe surveillance time.
Juniat V; Shah P; Vonica O; Daniel CS; Murta F
Eye (Lond); 2023 Apr; 37(5):971-976. PubMed ID: 35804019
[TBL] [Abstract][Full Text] [Related]
17. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Factors Influencing Resection Margin Involvement During Mohs Micrographic Surgery for Skin Tumors.
Chu J; Chung Y; Chae SW; Choi YJ; Kim HS; DO SI
Anticancer Res; 2023 Jun; 43(6):2707-2715. PubMed ID: 37247935
[TBL] [Abstract][Full Text] [Related]
19. Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan–Meier survival analysis of tumour recurrence.
Català A; Garces JR; Alegre M; Gich IJ; Puig L
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1363-9. PubMed ID: 25383396
[TBL] [Abstract][Full Text] [Related]
20. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
van Kester MS; Goeman JJ; Genders RE
J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
